
The observational study identifies immune biomarkers predictive of TACE response in unresectable hepatocellular carcinoma (uHCC). Among 50 patients, non-responders showed increased T cell senescence and exhaustion, and decreased memory stem T cells (TSCM). Flow cytometry and transcriptomic analysis revealed that CD8+ TSCM and Tsenescence levels strongly predict TACE outcomes, offering a potential non-invasive tool for personalized therapy selection.
Like
Save
Share